Update on RSV and New Vaccine Recommendation

Details

• Corporate Authors:
  National Center for Immunization and Respiratory Diseases (U.S.)
• Description:
  September 22, 2023, 5:00 PM EDT
  
  Key Takeaways
  
  • RSV season, which is typically in fall and winter, is right around the corner.
  
  • RSV activity has already started to increase in the Southeastern United States.
  
  • RSV can cause serious illness in infants, young children, and older adults. In fact, RSV is the leading reason that babies are hospitalized in the United States.
  
  • This year, we are in our strongest position ever with new RSV immunizations available to help protect babies, toddlers, and older adults from severe RSV. Most infants will likely only need protection from either the maternal RSV vaccine or the RSV immunization for babies, and not both.
  
  o Today, CDC recommended an RSV vaccine for people who are 32-36 weeks pregnant to protect their babies from severe RSV. The vaccine is recommended for seasonal use: in the continental US this generally means September through January. The seasonality of RSV season can vary, so state, local or territorial health departments may recommend different timing for administration for your area.
  
  o In August 2023, CDC recommended a new RSV immunization called nirsevimab to protect babies and some toddlers from severe RSV during the RSV season.
  
  
• Subjects:
  Respiratory Tract Infections Virus Diseases
• Document Type:
  Webpage
• Place as Subject:
  United States
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha256:a661948d577498a9efb0f62c11e66b29202423a8cc068ad3bb1302b7c4ebe72d
• Download URL:
  https://stacks.cdc.gov/view/cdc/133293/cdc_133293_DS1.pdf
• File Type:
  [PDF - 290.36 KB ]